Search Ontology:
ChEBI
saxagliptin
- Term ID
- CHEBI:71272
- Synonyms
-
- (1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile
- (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
- BMS 477118
- BMS-477118
- saxagliptin
- Definition
- A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2S)-amino(3-hydroxyadamantan-1-yl)acetic acid with the amino group of (1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carbonitrile. Used in its monohydrate form for the treatment of Type II diabetes.
- References
-
- cas:361442-04-8
- drugbank:DB06335
- drugcentral:4114
- hmdb:HMDB0015634
- kegg.drug:D08996
- patent:US2005222242
- patent:US2007172525
- patent:WO2007078726
- patent:WO2009022009
- patent:WO2011125011
- pubmed:22001114
- pubmed:22066527
- pubmed:22081481
- pubmed:22098472
- pubmed:22132773
- pubmed:22149373
- pubmed:22192246
- pubmed:22221000
- pubmed:22232748
- pubmed:22248301
- pubmed:22292415
- pubmed:22313154
- pubmed:22313172
- pubmed:22334441
- pubmed:22349123
- pubmed:22475049
- pubmed:22496391
- pubmed:22564773
- pubmed:22668067
- pubmed:22776778
- pubmed:22823746
- pubmed:22828124
- pubmed:22932707
- pubmed:22943617
- pubmed:23137182
- reaxys:10201614
- wikipedia.en:Saxagliptin
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from saxagliptin
Phenotype where environments contain saxagliptin
Phenotype modified by environments containing saxagliptin
Phenotype affecting saxagliptin
Human Disease Model